Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital and the National Heart & Lung Institute, Imperial College of Science and Medicine, Sydney Street, SW3 6NP London, UK.
Eur Heart J. 2010 Dec;31(24):3073-83. doi: 10.1093/eurheartj/ehq356. Epub 2010 Oct 7.
previous studies have established an association between exercise intolerance and increased morbidity and mortality in congenital heart disease patients. We aimed to clarify if exercise intolerance is associated with poor outcome in Fontan patients and to identify risk factors for mortality, transplantation, and cardiac-related hospitalization.
a total of 321 Fontan patients (57% male, mean age 20.9 ± 8.6 years) who underwent cardiopulmonary exercise testing (CPET) at four major European centres between 1997 and 2008 were included. During a median follow-up of 21 months, 22 patients died and 6 patients underwent cardiac transplantation (8.7%), resulting in an estimated 5-year transplant-free survival of 86%. Parameters of CPET were strongly related to increased risk of hospitalization, but-with the exception of heart rate reserve-unrelated to risk of death or transplantation. In contrast, patients with clinically relevant arrhythmia had a 6.0-fold increased risk of death or transplantation (P < 0.001). Furthermore, patients with atriopulmonary/-ventricular Fontan had a 3.7-fold increased risk of death or transplantation compared with total cavopulmonary connection patients (P= 0.009). The combination of clinically relevant arrhythmia, atriopulmonary/-ventricular Fontan, and signs of symptomatic or decompensated heart failure was associated with a particularly poor outcome (3-year mortality 25%).
on short-term follow-up, most parameters of CPET are associated with increased risk of hospitalization but not death or transplantation in contemporary Fontan patients. Only decreased heart rate reserve and a history of clinically relevant arrhythmia, atriopulmonary/-ventricular Fontan, and/or heart failure requiring diuretic therapy are associated with poor prognosis, potentially identifying patients requiring medical and/or surgical attention.
先前的研究已经证实,运动不耐受与先天性心脏病患者发病率和死亡率的增加有关。本研究旨在明确运动不耐受是否与 Fontan 患者预后不良相关,并确定死亡率、移植和心脏相关住院的危险因素。
共纳入 321 名 Fontan 患者(57%为男性,平均年龄 20.9±8.6 岁),他们于 1997 年至 2008 年在欧洲四个主要中心接受心肺运动测试(CPET)。在中位随访 21 个月期间,22 名患者死亡,6 名患者接受了心脏移植(8.7%),估计 5 年无移植生存率为 86%。CPET 的各项参数与住院风险增加密切相关,但除心率储备外,与死亡或移植风险无关。相比之下,有临床相关心律失常的患者死亡或移植的风险增加了 6 倍(P<0.001)。此外,与全腔静脉肺动脉连接患者相比,具有房室-肺动脉/静脉 Fontan 的患者死亡或移植的风险增加了 3.7 倍(P=0.009)。临床相关心律失常、房室-肺动脉/静脉 Fontan 和有症状或失代偿性心力衰竭的迹象的组合与预后不良(3 年死亡率为 25%)相关。
在短期随访中,CPET 的大多数参数与当代 Fontan 患者住院风险增加相关,但与死亡或移植无关。只有降低的心率储备以及临床相关心律失常、房室-肺动脉/静脉 Fontan 和/或需要利尿剂治疗的心力衰竭病史与预后不良相关,这可能确定需要医疗和/或手术关注的患者。